🔎 Trials Near Me

Home › Medulloblastoma › District of Columbia

Pag-aaral pangklinika para sa Medulloblastoma sa District of Columbia

7 pag-aaral para sa Medulloblastoma ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

  • Children's National Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07346157

Digoxin Medulloblastoma Study

  • Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

  • Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 4 hanggang 21 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 2
Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

  • Children's National Hospital, Washington D.C.
Nagre-recruit
12 Months – 39 Years · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05057702

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

  • Children's National Hospital, Washington D.C.
Nagre-recruitPhase 1
Edad 4 hanggang 30 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06514898

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

  • Children's National Hospital, Washington D.C.
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06193759

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.